Dr. Mark T. Murphy writes that ProSomnu EVO is efficient, easy, and saves time. Read more about its benefits here.
by Mark T. Murphy, DDS, D.ABDSM
Crossing the Chasm is a term related to the technology adoption lifecycle. The ‘chasm’ exists between the early adopters and early majority. When cell phones crossed the chasm, it was because the features, advantages and benefits enjoyed by early users were clearly appreciated by the rest of us. Using artificial intelligence, robotic manufacturing, and an innovative medical grade material, ProSomnus EVO is an Easy, Safe and Effective DSM device. Early adopters made EVO their ‘go-to’ right away and now the early majority are, too. With EVO, device selection is easier, there are fewer side effects, and the efficacy is better than legacy devices, according to data submitted by ProSomnus doctors. Let’s have a look at how EVO helps you Cross the Chasm!
Make it Easy
The ProSomnus portal offers transparency to cases, invoicing and payment options. It prevents ordering mishaps and shows every device design feature. The customer care and operations teams are trained to work with a full range of bite registration techniques – you choose what’s easy.
Send your best impressions or scans. ProSomnus accepts every kind of STL file – they were the first with a completely digital pathway to manufacture these medical devices. The precise fit ProSomnus is known for is even better with the MG6™ material of EVO. First time easy delivery and great fit without adjustments is standard. Doctors report scheduling shorter delivery appointments. Less time and stress – that’s easy.
Must be Safe
The smaller milled platforms provide more tongue space. This results in the need for less ‘dose,’ or advancement. Our doctors report less tooth movement, easier recapture of the MIP bite, and fewer adverse side effects. Milled PMMA and MG6™ both outperform others in device hygiene and staining. Other partially milled devices have hand-assembled advancement mechanisms or add soft liners that compromise precision and cleanability. Biogunk and stain have long affected physicians’ and patients’ views on OAT. Better devices, with fewer side effects that are easier to keep clean – that’s safe!
More Effective
Results matter. Better efficacy and excellent compliance delight patients, physicians, and payers. Recent studies show the true cost of CPAP is 2-3x that of OAT over 3 years. Physicians want therapeutic results; payers want lower costs; and patients want comfortable devices. ProSomnus is investing in clinical and RCT to establish OAT as a front-line therapy and demonstrate to the FDA a clearance for severe OSA, so more people can be treated – that’s effective!
Watch for more innovation from ProSomnus – our team is working to provide answers for all your office system needs, so you can continue your dental and your sleep practice with confidence and profitability.
For more about ProSomnus EVO, check out “Better Sleep Breathing Requires Better Tools,” at https://dentalsleeppractice.com/better-sleep-breathing-requires-better-tools/
Mark T. Murphy, DDS, D.ABDSM, is an American Board of Dental Sleep Medicine Diplomate and has practiced in the Rochester, MI area for 40 years. He is the Lead Faculty for Clinical Education at ProSomnus Sleep Technologies, serves on the DSM faculty at University of Detroit Mercy School of Dentistry and is a regular presenter on Dental Sleep Medicine at the Pankey Institute. He has served on the Board of Directors of the Pankey Institute, National Association of Dental Laboratories, the Identalloy Council, the Foundation for Dental Laboratory Technology, St. Vincent DePaul’s Dental Center, and the Dental Advisor. He lectures internationally on Leadership, Strategic Planning and Dental Sleep Medicine.